Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP known ✓ | O00591 | 2/20 | 0.31 |
| ▸ | GABRD known ✓ | O14764 | 2/20 | 0.31 |
| ▸ | GABRA1 known ✓ | P14867 | 2/20 | 0.31 |
| ▸ | GABRB1 known ✓ | P18505 | 2/20 | 0.31 |
| ▸ | GABRG2 known ✓ | P18507 | 2/20 | 0.31 |
| ▸ | GABRB3 known ✓ | P28472 | 2/20 | 0.31 |
| ▸ | GABRA5 known ✓ | P31644 | 2/20 | 0.31 |
| ▸ | GABRA3 known ✓ | P34903 | 2/20 | 0.31 |
| ▸ | GABRA2 known ✓ | P47869 | 2/20 | 0.31 |
| ▸ | GABRB2 known ✓ | P47870 | 2/20 | 0.31 |
| ▸ | GABRA4 known ✓ | P48169 | 2/20 | 0.31 |
| ▸ | GABRE known ✓ | P78334 | 2/20 | 0.31 |
| ▸ | GABRA6 known ✓ | Q16445 | 2/20 | 0.31 |
| ▸ | GABRG1 known ✓ | Q8N1C3 | 2/20 | 0.31 |
| ▸ | GABRG3 known ✓ | Q99928 | 2/20 | 0.31 |
| ▸ | GABRQ known ✓ | Q9UN88 | 2/20 | 0.31 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL54007 | 0.98 | TGFBR1 (0.38) | TGFBR1RXFP1TDP1TSHRCYP2D6 | |
| SCHEMBL30176231 | 0.82 | CYP2D6 (0.40) | CYP2D6CYP2C19KDM4EPOLBGABRP | |
| SCHEMBL9759560 | 0.81 | TGFBR1 (0.38) | TGFBR1RXFP1TDP1ALDH1A1 | |
| SCHEMBL24369549 | 0.81 | CYP2D6 (0.33) | CYP2D6CYP2C19GABRPGABRDGABRA1 | |
| SCHEMBL366427 | 0.80 | CYP2D6 (0.52) | TGFBR1RXFP1TDP1TSHRCYP2D6 | |
| Hydrochloric Acid SCHEMBL720229 | 0.80 | ANPEP (0.43) | TGFBR1RXFP1TDP1TSHRGABRP | |
| SCHEMBL16097 | 0.78 | TGFBR1 (0.39) | TGFBR1RXFP1TDP1TSHRCYP2D6 | |
| SCHEMBL12642676 | 0.78 | TGFBR1 (0.39) | TGFBR1RXFP1TDP1TSHRCYP2D6 | |
| SCHEMBL9289423 | 0.78 | TGFBR1 (0.39) | TGFBR1RXFP1TDP1TSHRCYP2D6 | |
| SCHEMBL10187391 | 0.78 | GFPT1 (0.46) | TGFBR1SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4729167-A1 | FLOW REACTOR AND BIOLOGICAL POLYMER SYNTHESIS SYSTEM INCLUDING SAME | SP2TX Inc. (KR) | 2026-04-22 | — | — | EP | disclosed |
| WO-2025071365-A1 | FLOW REACTOR AND BIOLOGICAL POLYMER SYNTHESIS SYSTEM INCLUDING SAME | 에스피투티엑스주식회사 | 2025-04-03 | — | — | WO | disclosed |
| WO-2023234718-A1 | MEMBRANE FOR BIOPOLYMER SYNTHESIS AND BIOPOLYMER SYNTHESIS METHOD USING SAME | 바이오센서연구소 주식회사 | 2023-12-07 | — | — | WO | disclosed |
| CN-105309424-B | Method for producing polymer nanoparticles and preparation of active ingredients | 维乌作物保护有限公司 | 2022-09-02 | — | — | CN | disclosed |
| US-20220211035-A1 | METHODS TO FORMULATE NEUTRAL ORGANIC COMPOUNDS WITH POLYMER NANOPARTICLES | SILICON VALLEY BANK (CA) | 2022-07-07 | — | — | US | disclosed |
| CN-216677758-U | Composite porous filtering membrane and filter | 恩特格里斯公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-113828164-A | Composite filter media | 恩特格里斯公司 | 2021-12-24 | — | — | CN | disclosed |
| EP-3378310-B1 | METHODS TO PRODUCE POLYMER NANOPARTICLES AND FORMULATIONS OF ACTIVE INGREDIENTS | VIVE CROP PROT INC (CA) | 2021-08-04 | — | — | EP | disclosed |
| US-20200260724-A1 | METHODS TO FORMULATE NEUTRAL ORGANIC COMPOUNDS WITH POLYMER NANOPARTICLES | SILICON VALLEY BANK (CA) | 2020-08-20 | — | — | US | disclosed |
| US-20190307129-A1 | METHODS TO PRODUCE POLYMER NANOPARTICLES AND FORMULATIONS OF ACTIVE INGREDIENTS | VIVE CROP PROTECTION INC. (CA) | 2019-10-10 | — | — | US | disclosed |
| US-20100210465-A1 | METHODS TO PRODUCE POLYMER NANOPARTICLES AND FORMULATIONS OF ACTIVE INGREDIENTS | VIVE NANO, INC. (CA) | 2010-08-19 | — | — | US | disclosed |
| WO-2010035118-A1 | METHODS TO PRODUCE POLYMER NANOPARTICLES AND FORMULATIONS OF ACTIVE INGREDIENTS | VIVE NANO, INC. (CA) | 2010-04-01 | — | — | WO | disclosed |
| EP-0677589-B1 | Method, test element and test kit for semi-quantitative detection of target nucleic acid | JOHNSON & JOHNSON CLIN DIAG (US) | 2001-05-16 | — | — | EP | disclosed |
| US-5888723-A | SENSITIVE HYBRIDIZATION ASSAY USING NUCLEIC ACID REAGENT COMPOSED OF OLIGONUCLEOTIDES COVALENTLY ATTACHED TO POLYMER PARTICLES WHICH ARE ADHERED TO SUPPORT USING WATER INSOLUBLE ADHESIVE; LOW BACKGROUND | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1999-03-30 | — | — | US | disclosed |
| US-5591580-A | Method, test element and test kit for semi-quantitative detection of target nucleic acid | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1997-01-07 | — | — | US | disclosed |
| EP-0530357-B1 | ELEMENT AND METHOD FOR NUCLEIC ACID AMPLIFICATION AND DETECTION USING ADHERED PROBES | JOHNSON & JOHNSON CLIN DIAG (US) | 1995-11-15 | — | — | EP | disclosed |
| EP-0677589-A2 | Method, test element and test kit for semi-quantitative detection of target nucleic acid | Johnson & Johnson Clinical Diagnostics, Inc. (US) | 1995-10-18 | — | — | EP | disclosed |
| US-5380489-A | Element and method for nucleic acid amplification and detection using adhered probes | EASTMAN KODAK COMPANY (US) | 1995-01-10 | — | — | US | disclosed |
| EP-0530357-A1 | ELEMENT AND METHOD FOR NUCLEIC ACID AMPLIFICATION AND DETECTION USING ADHERED PROBES. | EASTMAN KODAK CO (US) | 1993-03-10 | — | — | EP | disclosed |
| WO-1992016659-A1 | ELEMENT AND METHOD FOR NUCLEIC ACID AMPLIFICATION AND DETECTION USING ADHERED PROBES | EASTMAN KODAK COMPANY (US) | 1992-10-01 | — | — | WO | disclosed |